secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROKIDNEY CORP. (PROK)
CIK:        0001850270
Form:       8-K/A
Filed at:   2024-03-18T23:59:59+00:00
Accession:  0000950170-24-032827
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ProKidney Corp. finalizes separation agreement with former COO Deepak Jain including $495K severance
--------------------------------------------------------------------------------

- Severance pay of $495,000 (12 months base salary) plus eligibility for 2023 bonus up to 45% of base salary.
- Company will pay 100% of COBRA/Medicare premiums through November 30, 2024.
- Legal fee reimbursement up to $20,000 for negotiation of separation agreement.
- Vested stock options exercisable for 90 days after effective date; all unvested awards forfeited.
- Vested Class B shares: 783,969 convertible to Class A; 406,087 remain under lockup until July 11, 2026 or regulatory event.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850270/000095017024032827/0000950170-24-032827-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850270/000095017024032827/prok-20231128.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-032827

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer